Clinical trial Recruiting at 1 site Observational Ages 18 and up

Identifying biomarkers for early diagnosis of motor neuron diseases

Official title: Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis

Run by University of Dublin, Trinity College · NCT05663008 · Data updated 2026-11-12

This study is trying to find new ways to diagnose motor neuron diseases early by looking at brain and muscle signals in patients to help improve their care.

More Spinal Muscular Atrophy trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorUniversity of Dublin, Trinity College
Academic / other
Locations1 site (Dublin, Leinster)
StatusRecruiting
StartedOctober 1, 2015
Main results expectedJanuary 30, 2027
Study endsSeptember 30, 2027
Registry record updatedDecember 23, 2022
Trial IDNCT05663008 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with ALS, postpoliomyelitis syndrome, spinal muscular atrophy, or related conditions who can provide informed consent.

Probably not a fit

Patients with active psychiatric diseases or severe neuropathy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify non-invasive neurophysiological biomarkers for early diagnosis and progression monitoring in patients with motor neuron diseases such as ALS, postpoliomyelitis syndrome, and spinal muscular atrophy. By analyzing joint recordings of electroencephalography (EEG) and surface electromyography (sEMG), the study seeks to distinguish between healthy individuals and various patient subgroups. The goal is to enhance personalized diagnosis and improve clinical care through reliable quantitative measures that can facilitate timely entry into clinical trials.

Why it matters

Potential benefit: If successful, this study could lead to earlier and more personalized diagnoses for patients with motor neuron diseases, improving their clinical care.

How similar studies have gone: While there have been various investigations into biomarkers for ALS, this specific approach using combined EEG and sEMG is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Healthy Volunteers:

* age and gender-matched to patient groups
* the intact physical ability to take part in the experiment.

Patients:

* Diagnosis of ALS, PLS, PMA, SMA, Polio or MS
* capable of providing informed consent.

Exclusion Criteria:

Healthy Controls:

* History of neuromuscular
* neurological or active psychiatric disease disease
* history of reaction or allergy to recording environments, equipment and the recording gels.

Patients:

* the presence of active psychiatric disease
* any medical condition associated with severe neuropathy (e.g. poorly controlled diabetes).
* History of reaction or allergy to recording environments, equipment and the recording gels.

Where it's running

  • Academic Unit of Neurology, Trinity College Dublin, The University of Dublin
    Dublin, Leinster, Ireland
    Recruiting

Study contacts

  • Principal investigator: Orla Hardiman, BSc MB BCh BAO MD FRCPI FAAN — Academic Unit of Neurology, Trinity College Dublin, The University of Dublin
  • Study coordinator: Orla Hardiman, BSc MB BCh BAO MD FRCPI FAAN
  • Email: hardimao@tcd.ie
  • Phone: +353 1 896 4497

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.